Anti-TNF for post-operative prevention in Crohn's disease: the detection of anti-drug antibodies at time of surgery is associated with an increased risk of endoscopic recurrence

被引：0
|
作者：
Auzolle, C. [1 ]
Houze, P. [2 ]
Tran-Minh, M. -L. [1 ]
Nancey, S. [3 ]
Buisson, A. [4 ]
Fumery, M. [5 ]
Pariente, B. [6 ]
Djenidi, F. [1 ]
Marteau, P. [7 ]
Bouhnik, Y. [8 ]
Seksik, P. [7 ]
Allez, M. [7 ]
机构：
[1] St Louis Hosp, Dept Gastroenterol, Paris, France
[2] St Louis Hosp, Dept Biochem, Paris, France
[3] Lyon Sud Hosp, Hosp Civils Lyon, Dept Gastroenterol, Pierre Benite, France
[4] CHU Estaing, Dept Gastroenterol, Clermont Ferrand, France
[5] CHU Amiens, Dept Gastroenterol, Amiens, France
[6] Claude Huriez Hosp, Dept Gastroenterol, Lille, France
[7] St Antoine Hosp, Dept Gastroenterol, Paris, France
[8] Beaujon Hosp, Dept Gastroenterol, Clichy, France
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P420
引用
收藏
页码：S290 / S290
页数：1
相关论文
共 50 条
  • [31] Strategies in the prevention of post-operative recurrence in Crohn's disease
    Rutgeerts, P
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2003, 17 (01) : 63 - 73
  • [32] Is Anti-TNF Therapy Associated With an Increased Risk of Postoperative Morbidity After Surgery for Ileocolonic Crohn Disease?
    Mege, Diane
    Michelassi, Fabrizio
    ANNALS OF SURGERY, 2018, 267 (02) : 229 - 230
  • [33] Identification of Gene Expression Profiles Associated with an Increased Risk of Post-Operative Recurrence in Crohn's Disease
    Ngollo, Marjolaine
    Perez, Kevin
    Hammoudi, Nassim
    Gorelik, Yuri
    Delord, Marc
    Auzolle, Claire
    Bottois, Hugo
    Cazals-Hatem, Dominique
    Bezault, Madeleine
    Nancey, Stephane
    Pariente, Benjamin
    Treton, Xavier
    Fumery, Mathurin
    Buisson, Anthony
    Barnich, Nicolas
    Seksik, Philippe
    Shen-Orr, Shai S.
    Le Bourhis, Lionel
    Allez, Matthieu
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (08): : 1269 - 1280
  • [34] Post-operative use of anti-TNFα agents in patients with Crohn's disease and risk of re-operation - a nationwide cohort study
    Kjeldsen, J.
    Nielsen, J.
    Larsen, M. D.
    Qvist, N.
    Norgaard, B.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S16 - S16
  • [35] Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease
    Ha, Christina
    Mathur, Jagrati
    Kornbluth, Asher
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (04) : 497 - 505
  • [36] ANTI-TNF DRUG ANTIBODY LEVELS CORRELATE WITH POST-SURGICAL RECURRENCE IN CROHN'S DISEASE (CD)
    Pajot, Gregory
    Sunjaya, Dharma
    Ebner, Derek
    Ho, Ivan
    Eckmann, Jason
    Oblizajek, Nicholas R.
    Papadakis, Konstantinos A.
    GASTROENTEROLOGY, 2018, 154 (01) : S7 - S7
  • [37] ANTI-TNF DRUG ANTIBODY LEVELS CORRELATE WITH POST-SURGICAL RECURRENCE IN CROHN'S DISEASE (CD)
    Pajot, Gregory
    Sunjaya, Dharma
    Ebner, Derek
    Ho, Ivan
    Eckmann, Jason
    Oblizajek, Nicholas R.
    Papadakis, Konstantinos A.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S5 - S5
  • [38] Systematic review: the use of thiopurines or anti-TNF in post-operative Crohn's disease maintenance-progress and prospects
    Jones, G. R.
    Kennedy, N. A.
    Lees, C. W.
    Arnott, I. D.
    Satsangi, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (11) : 1253 - 1265
  • [39] Risk factors for the development of anti-drug antibodies to infliximab and adalimumab in Crohn's disease
    Khoo, E.
    Lord, A.
    Hanigan, K.
    Croft, A.
    Radford-Smith, G.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S378 - S379
  • [40] Utility of Measuring Serum Concentrations of Anti-TNF Agents and Anti-Drug Antibodies in Inflammatory Bowel Disease
    Guerra, Ivan
    Chaparro, Maria
    Bermejo, Fernando
    Gisbert, Javier P.
    CURRENT DRUG METABOLISM, 2011, 12 (06) : 594 - 598
12345